Excerpt from: Reuters (click for full article)
Health policy researchers at the University of
California, San Francisco, who set out to examine conflict of interest
policies for the 47 U.S. states plus the District of Columbia with
Medicaid Preferred Drug List committees, found that many have no policy,
and in the states that do, rules vary widely.
"The
take home message is that there is no such thing as typical. There is
no such thing as a uniformed process," said Lisa Bero, the study's lead
author.
For Medicaid, the federal-
and state-funded insurance program for poor Americans, decisions to pay
for drugs are left up to a state committee that's made up of doctors,
pharmacists and other healthcare professionals.
The
U.S. Centers for Medicare and Medicaid Services, which oversees the
federal part of the insurance program, requires that two members of
those committees be free of conflicts of interest, but the agency does
not define what constitutes a conflict.
Recent Comments